nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.331	0.511	CbGbCtD
Cinitapride—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.316	0.489	CbGbCtD
Cinitapride—HTR2A—arteriole—type 2 diabetes mellitus	0.0198	0.255	CbGeAlD
Cinitapride—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.0126	0.163	CbGeAlD
Cinitapride—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00848	0.109	CbGeAlD
Cinitapride—HTR2A—hindlimb—type 2 diabetes mellitus	0.00784	0.101	CbGeAlD
Cinitapride—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00612	0.0788	CbGeAlD
Cinitapride—HTR2A—artery—type 2 diabetes mellitus	0.00481	0.0619	CbGeAlD
Cinitapride—HTR2A—nerve—type 2 diabetes mellitus	0.00477	0.0614	CbGeAlD
Cinitapride—HTR2A—endothelium—type 2 diabetes mellitus	0.00406	0.0523	CbGeAlD
Cinitapride—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.0028	0.0361	CbGeAlD
Cinitapride—HTR2A—retina—type 2 diabetes mellitus	0.00197	0.0254	CbGeAlD
Cinitapride—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.00167	0.0215	CbGeAlD
Cinitapride—HTR2A—kidney—type 2 diabetes mellitus	0.00163	0.0211	CbGeAlD
Cinitapride—HTR2A—liver—type 2 diabetes mellitus	0.00103	0.0133	CbGeAlD
Cinitapride—HTR2A—Signaling by GPCR—IAPP—type 2 diabetes mellitus	9.77e-05	0.000355	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GCG—type 2 diabetes mellitus	9.75e-05	0.000354	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	9.72e-05	0.000353	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	9.71e-05	0.000353	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	9.71e-05	0.000352	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GHRL—type 2 diabetes mellitus	9.68e-05	0.000351	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.64e-05	0.00035	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	9.59e-05	0.000348	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CALCA—type 2 diabetes mellitus	9.56e-05	0.000347	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	9.54e-05	0.000346	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—CCL2—type 2 diabetes mellitus	9.54e-05	0.000346	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	9.49e-05	0.000344	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	9.45e-05	0.000343	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	9.36e-05	0.00034	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MC4R—type 2 diabetes mellitus	9.25e-05	0.000336	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	9.25e-05	0.000336	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—INS—type 2 diabetes mellitus	9.23e-05	0.000335	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	9.21e-05	0.000334	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TLE4—type 2 diabetes mellitus	9.11e-05	0.00033	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	9.1e-05	0.00033	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	9.09e-05	0.00033	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.08e-05	0.00033	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.93e-05	0.000324	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.92e-05	0.000324	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GIP—type 2 diabetes mellitus	8.91e-05	0.000323	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.89e-05	0.000323	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GCG—type 2 diabetes mellitus	8.85e-05	0.000321	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	8.82e-05	0.00032	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRB3—type 2 diabetes mellitus	8.76e-05	0.000318	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	8.71e-05	0.000316	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	8.58e-05	0.000311	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.48e-05	0.000308	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	8.47e-05	0.000307	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LEPR—type 2 diabetes mellitus	8.46e-05	0.000307	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	8.44e-05	0.000306	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GCG—type 2 diabetes mellitus	8.42e-05	0.000306	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	8.4e-05	0.000305	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	8.4e-05	0.000305	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	8.39e-05	0.000304	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GHRL—type 2 diabetes mellitus	8.36e-05	0.000303	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AVP—type 2 diabetes mellitus	8.29e-05	0.000301	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	8.29e-05	0.000301	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CALCA—type 2 diabetes mellitus	8.26e-05	0.0003	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—CCL2—type 2 diabetes mellitus	8.24e-05	0.000299	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.1e-05	0.000294	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.1e-05	0.000294	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	8.09e-05	0.000293	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	7.88e-05	0.000286	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TLE4—type 2 diabetes mellitus	7.87e-05	0.000285	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	7.81e-05	0.000284	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	7.74e-05	0.000281	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	7.74e-05	0.000281	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GCG—type 2 diabetes mellitus	7.65e-05	0.000278	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	7.63e-05	0.000277	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—RELA—type 2 diabetes mellitus	7.62e-05	0.000277	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRB3—type 2 diabetes mellitus	7.57e-05	0.000275	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RBP4—type 2 diabetes mellitus	7.54e-05	0.000274	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	7.54e-05	0.000274	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AVP—type 2 diabetes mellitus	7.53e-05	0.000273	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	7.53e-05	0.000273	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	7.52e-05	0.000273	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	7.49e-05	0.000272	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.42e-05	0.000269	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	7.31e-05	0.000265	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	7.26e-05	0.000263	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AVP—type 2 diabetes mellitus	7.16e-05	0.00026	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	7.16e-05	0.00026	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	7.05e-05	0.000256	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.94e-05	0.000252	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	6.89e-05	0.00025	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.87e-05	0.000249	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.83e-05	0.000248	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	6.81e-05	0.000247	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	6.8e-05	0.000247	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	6.75e-05	0.000245	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	6.72e-05	0.000244	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	6.69e-05	0.000243	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	6.69e-05	0.000243	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	6.68e-05	0.000243	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—INSR—type 2 diabetes mellitus	6.64e-05	0.000241	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	6.59e-05	0.000239	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	6.54e-05	0.000238	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.53e-05	0.000237	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RBP4—type 2 diabetes mellitus	6.52e-05	0.000237	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	6.52e-05	0.000237	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.52e-05	0.000237	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	6.5e-05	0.000236	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AVP—type 2 diabetes mellitus	6.5e-05	0.000236	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.5e-05	0.000236	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	6.49e-05	0.000236	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.49e-05	0.000235	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	6.47e-05	0.000235	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.43e-05	0.000233	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	6.41e-05	0.000233	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.4e-05	0.000232	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.3e-05	0.000229	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—C3—type 2 diabetes mellitus	6.25e-05	0.000227	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.21e-05	0.000225	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	6.19e-05	0.000224	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	6.09e-05	0.000221	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	6.05e-05	0.000219	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.03e-05	0.000219	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.03e-05	0.000219	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SRC—type 2 diabetes mellitus	5.99e-05	0.000217	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—C3—type 2 diabetes mellitus	5.95e-05	0.000216	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.94e-05	0.000216	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	5.88e-05	0.000213	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.87e-05	0.000213	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.84e-05	0.000212	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.84e-05	0.000212	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.83e-05	0.000212	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	5.81e-05	0.000211	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IAPP—type 2 diabetes mellitus	5.77e-05	0.00021	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	5.74e-05	0.000208	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—INSR—type 2 diabetes mellitus	5.74e-05	0.000208	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	5.72e-05	0.000208	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	5.72e-05	0.000208	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	5.65e-05	0.000205	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	5.65e-05	0.000205	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	5.64e-05	0.000205	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	5.63e-05	0.000204	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	5.61e-05	0.000203	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	5.53e-05	0.000201	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.49e-05	0.000199	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—C3—type 2 diabetes mellitus	5.4e-05	0.000196	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	5.37e-05	0.000195	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.35e-05	0.000194	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.32e-05	0.000193	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.29e-05	0.000192	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.25e-05	0.000191	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	5.23e-05	0.00019	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.23e-05	0.00019	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	5.22e-05	0.00019	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	5.21e-05	0.000189	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	5.21e-05	0.000189	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.15e-05	0.000187	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AGT—type 2 diabetes mellitus	5.13e-05	0.000186	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.13e-05	0.000186	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	5.07e-05	0.000184	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	5.05e-05	0.000183	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CYBA—type 2 diabetes mellitus	5.05e-05	0.000183	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	4.96e-05	0.00018	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	4.94e-05	0.000179	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	4.94e-05	0.000179	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.89e-05	0.000178	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	4.88e-05	0.000177	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.81e-05	0.000175	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.8e-05	0.000174	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	4.74e-05	0.000172	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	4.6e-05	0.000167	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	4.57e-05	0.000166	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.55e-05	0.000165	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	4.52e-05	0.000164	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GCG—type 2 diabetes mellitus	4.52e-05	0.000164	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.51e-05	0.000164	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	4.45e-05	0.000161	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.45e-05	0.000161	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	4.44e-05	0.000161	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	4.43e-05	0.000161	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.43e-05	0.000161	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.41e-05	0.00016	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.36e-05	0.000158	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	4.3e-05	0.000156	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.28e-05	0.000155	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.23e-05	0.000154	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.23e-05	0.000153	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.15e-05	0.000151	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.15e-05	0.000151	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	4.1e-05	0.000149	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6—type 2 diabetes mellitus	4.03e-05	0.000146	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.02e-05	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	3.93e-05	0.000143	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	3.89e-05	0.000141	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.85e-05	0.00014	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AVP—type 2 diabetes mellitus	3.84e-05	0.000139	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	3.84e-05	0.000139	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	3.82e-05	0.000139	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	3.81e-05	0.000138	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.78e-05	0.000137	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	3.77e-05	0.000137	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.72e-05	0.000135	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOB—type 2 diabetes mellitus	3.71e-05	0.000135	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.7e-05	0.000134	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	3.69e-05	0.000134	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.65e-05	0.000133	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LPL—type 2 diabetes mellitus	3.55e-05	0.000129	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.52e-05	0.000128	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.52e-05	0.000128	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.51e-05	0.000127	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.47e-05	0.000126	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.45e-05	0.000125	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	3.44e-05	0.000125	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	3.44e-05	0.000125	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.4e-05	0.000123	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.33e-05	0.000121	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.27e-05	0.000119	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.24e-05	0.000118	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—C3—type 2 diabetes mellitus	3.19e-05	0.000116	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.07e-05	0.000111	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.04e-05	0.00011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.04e-05	0.00011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.03e-05	0.00011	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.98e-05	0.000108	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	2.97e-05	0.000108	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	2.97e-05	0.000108	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.94e-05	0.000107	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.94e-05	0.000107	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.89e-05	0.000105	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.84e-05	0.000103	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.84e-05	0.000103	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.83e-05	0.000103	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.8e-05	0.000102	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.7e-05	9.8e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.65e-05	9.62e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.58e-05	9.35e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.58e-05	9.35e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	2.54e-05	9.21e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.5e-05	9.07e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.46e-05	8.91e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.45e-05	8.91e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.44e-05	8.87e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.43e-05	8.8e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.33e-05	8.46e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.23e-05	8.08e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.23e-05	8.08e-05	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.21e-05	8.01e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.19e-05	7.94e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.17e-05	7.89e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.1e-05	7.61e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.07e-05	7.5e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.05e-05	7.42e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.01e-05	7.28e-05	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.91e-05	6.92e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.91e-05	6.92e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.89e-05	6.86e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.88e-05	6.82e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.86e-05	6.74e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.79e-05	6.48e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.77e-05	6.41e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.73e-05	6.29e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.7e-05	6.18e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.67e-05	6.06e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.65e-05	5.98e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.6e-05	5.82e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.47e-05	5.34e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.44e-05	5.24e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.28e-05	4.66e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.18e-05	4.3e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.11e-05	4.03e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.02e-05	3.71e-05	CbGpPWpGaD
